ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
INTERFERONUM
Active substance (INN) · 0 products authorised in Romania
1
Protocols it appears in
As a medicine of the protocol (in the title) or only mentioned in the text
| Code | Protocol | Status | Role | Sublist | GP |
|---|---|---|---|---|---|
| J006N | INTERFERONUM ALFA 2B | In force | medicine of the protocol | C1-G4 si G7 doar pentru pacienţii cu afectare renală consecutivă infecţiei cu virusuri hepatitice | NO |
| J007N | INTERFERONUM ALFA 2A | In force | medicine of the protocol | C1-G4 si G7 doar pentru pacienţii cu afectare renală consecutivă infecţiei cu virusuri hepatitice | NO |
| J05AP | Hepatită cronică şi Ciroză hepatică cu VHC, cu medicamente cu acțiune antivirală directă (interferon-free) | In force | medicine of the protocol | C1-G4 si G7 | NO |
| L016C | INTERFERON ALFA 2B | In force | medicine of the protocol | C2-P3 | NO |
| L050C | INTERFERONUM ALFA 2A | In force | medicine of the protocol | C2-P3 | NO |
| B013K | MEDICAŢIA ADJUVANTĂ TERAPIEI ANTIVIRALE ÎN HEPATITE CRONICE (FILGRASTIM) | In force | mentioned in the text | C1-G4, G7 | * |
| B02BX08 | AVATROMBOPAG | In force | mentioned in the text | C2-P6.27/C1-G10 | NO |
| H006C | TUMORI NEUROENDOCRINE - TRATAMENT CU ANALOGI DE SOMATOSTATINĂ | In force | mentioned in the text | C1-G22 | NO |
| J05AX28 | BULEVIRTIDUM | In force | mentioned in the text | C1-G4 si G7 | NO |
| J07BB02-03 | VACCIN GRIPAL | In force | mentioned in the text | E-E1 si E2 | YES |
| L004C | BEVACIZUMABUM | In force | mentioned in the text | C2-P3 | NO |
| L008C | IMATINIBUM | In force | mentioned in the text | C2-P3 | YES |
| L01EK03 | TIVOZANIBUM | In force | mentioned in the text | C2-P3 | YES |
| L01XC-L04AJ | VASCULITE ANCA POZITIVE - DCI RITUXIMABUM**1 (original și biosimilar) și DCI AVACOPAN**1Ω | In force | mentioned in the text | C1-G17 | NO |
| L01XC02 | RITUXIMABUM | In force | mentioned in the text | C1-G17 | NO |
| L038C | SORAFENIBUM | In force | mentioned in the text | C2-P3 | YES |
| L039M | ARTRITA IDIOPATICĂ JUVENILĂ - AGENŢI BIOLOGICI: ADALIMUMABUM**1 (original și biosimilar), ETANERCEPTUM**1 (original și biosimilar), ABATACEPTUM**1, TOCILIZUMABUM**1(origi… | In force | mentioned in the text | C1-G31E | NO |
| L040M | ARTRITA PSORIAZICĂ – AGENŢI BIOLOGICI: ADALIMUMABUM**1 (ORIGINAL ŞI BIOSIMILAR), CERTOLIZUMABUM**1, ETANERCEPTUM**1 (ORIGINAL ŞI BIOSIMILAR), GOLIMUMABUM**1, INFLIXIMABUM… | In force | mentioned in the text | C1-G31C | NO |
| L041M | SPONDILOARTRITA AXIALĂ, INCLUZÂND SPONDILITA ANCHILOZANTĂ ȘI SPONDILOARTRITA AXIALĂ NONRADIOGRAFICĂ - AGENŢI BIOLOGICI: ADALIMUMABUM**1 (ORIGINAL ŞI BIOSIMILAR), CERTOLIZ… | In force | mentioned in the text | C1-G31D | NO |
| L042C | SUNITINIBUM | In force | mentioned in the text | C2-P3 | YES |
| L043M | POLIARTRITA REUMATOIDĂ - AGENŢI BIOLOGICI: INFLIXIMABUM**1 (ORIGINAL ŞI BIOSIMILAR), ETANERCEPTUM**1 (ORIGINAL ŞI BIOSIMILAR), ADALIMUMABUM**1 (ORIGINAL ŞI BIOSIMILAR), G… | In force | mentioned in the text | C1-G31B | NO |
| L044L | PSORIAZIS CRONIC SEVER (ÎN PLĂCI) - AGENŢI BIOLOGICI ŞI TERAPII CU MOLECULE MICI CU ACŢIUNE INTRACELULARĂ | In force | mentioned in the text | C1-G31F | YES |
| L04AA26-51 | LUPUS ERITEMATOS SISTEMIC - AGENŢI BIOLOGICI: BELIMUMABUM**1, ANIFROLUMABUM**1 | In force | mentioned in the text | C1-G17 | NO |
| L04AB04-UV | ADALIMUMABUM | In force | mentioned in the text | C1-G18 | NO |
| L04AC03 | ANAKINRA | In force | mentioned in the text | C1-G31i | NO |
| L04AC08 | CANAKINUMABUM | In force | mentioned in the text | C1-G31I | NO |
| LB01B | HEPATITĂ CRONICĂ ŞI CIROZĂ HEPATICĂ CU VIRUS VHB | In force | mentioned in the text | C1-G4,G7 | YES |
2
History: entries into and exits from protocols
| Month | Type | Code | Protocol | Level |
|---|---|---|---|---|
| April 2026 | Medicine added | B02BX08 | AVATROMBOPAG | mentioned in the text |
3
Authorised brand products (ANMDM)
The Romanian register of medicines for human use, updated daily
No product with this substance in the ANMDM register (a new medicine, or one authorised only centrally in the EU).